Brief: Sosei Group Has Bought Swiss Idorsia Pharmaceuticals' Japan And South Korea Businesses For About 65 Billion Yen - Nikkei
July 20 (Reuters) - Sosei Group Corp 4565.T :
* SOSEI GROUP HAS BOUGHT SWISS IDORSIA PHARMACEUTICALS'
JAPAN AND
SOUTH KOREA BUSINESSES FOR ABOUT 65 BILLION YEN - NIKKEI
Source text for Eikon: ID:
Further company coverage: 4565.T
(Reporting by Satoshi Sugiyama)
((Satoshi.Sugiyama@thomsonreuters.com;))
Recent news on Nxera Pharma
See all newsNxera Pharma Submits Marketing Authorization Application For Vamorolone In South Korea For Treatment Of Duchenne Muscular Dystrophy
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Nxera Pharma - Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia-Pacific Markets
Brief: Nxera Announces Successful Resolution Of Minig Patent Infringement Action
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up